Woman's Bid to End Prescription Drug Sales on eBay
said. Does Amazon Have a Prescription Drug Problem? What You Need to Know About the Enterovirus Outbreak FDA OKs Merck Melanoma Drug Every time White makes a complaint, she said the company responds by removing the offending listings. But they’re usually
New Drug Shows Promise In Treating Melanoma
Dr. Kevin Kim says vemurafenib showed a high percentage of tumor shrinkage.
New Drug Promising Against Deadly Melanoma
clinical trial of a medication called vemurafenib , that he began to turn the corner on ..... treatment. In about half of them, vemurafenib shrunk their tumors. For another third ..... hope. Unlike many other cancer drugs, vemurafenib was just as effective in patients who
New Melanoma Drug Approved
FDA gives skin cancer treatment Zelboraf stamp of approval.
FDA Approves Skin Cancer Drug Zelboraf
approved the second late-stage melanoma drug this year, adding the drug ..... cancer. The drug, known as Zelboraf , could offer hope for patients ..... with surgery, experts said. Zelboraf , which was reviewed under ..... randomized to receive either Zelboraf or a standard chemotherapy
Revolutionary New Drug Targets Deadly Skin Cancer
to an experimental drug called Vemurafenib , which launches a targeted attack on the cancer's very source. Vemurafenib , which is being developed by Plexxikon ..... percent of patients treated with Vemurafenib were alive six months later, compared
New Cancer Drugs Raise Hope of Survival
decided to try an experimental drug called Vemurafenib . Now, Corcoran said, the drug has ..... is fantastic," he said. Drugs like Vemurafenib , the one Corcoran tried, are what ..... University of Pennsylvania said. The drug Vemurafenib , which is being developed by Plexxikon
Melanoma Drug Boosts Recurrence-Free Survival
Pegylated inteferon cut risk 15% but did not reduce overall mortality rates.
Health Highlights: April 8, 2008
My daughter is fine -- like any other child," said father Vinod Singh, a poor farm worker. ----- Pfizer Halts Melanoma Drug Trial A late-stage study of the experimental melanoma treatment tremelimumab has been halted by drug maker Pfizer Inc